Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.18
-0.01 (-0.19%)
Sep 15, 2025, 11:07 AM EDT - Market open
Foghorn Therapeutics Employees
Foghorn Therapeutics had 112 employees as of December 31, 2024. The number of employees decreased by 4 or -3.45% compared to the previous year.
Employees
112
Change (1Y)
-4
Growth (1Y)
-3.45%
Revenue / Employee
$215,830
Profits / Employee
-$673,170
Market Cap
292.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 112 | -4 | -3.45% |
| Dec 31, 2023 | 116 | -45 | -27.95% |
| Dec 31, 2022 | 161 | 42 | 35.29% |
| Dec 31, 2021 | 119 | 24 | 25.26% |
| Dec 31, 2020 | 95 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
FHTX News
- 18 days ago - IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies - PRNewsWire
- 19 days ago - Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update - GlobeNewsWire
- 4 months ago - Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Foghorn Therapeutics Provides First Quarter 2025 Financial and Corporate Update - GlobeNewsWire
- 4 months ago - Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference - GlobeNewsWire
- 4 months ago - Foghorn Therapeutics Appoints Neil Gallagher and Stuart Duty to its Board of Directors - GlobeNewsWire
- 4 months ago - Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update - GlobeNewsWire